 |
Company Summary
Bristol-Myers Squibb Company, a global biopharmaceutical company, engages in discovering, developing, and delivering medicines that help patients prevail over serious diseases. The company focuses on areas of serious unmet medical need, such as:
- affective (psychiatric) disorders
- Alzheimer’s/dementia
- cardiovascular (primarily atherosclerosis/thrombosis)
- diabetes
- hepatitis
|
|
- HIV/AIDS
- obesity, oncology
- rheumatoid arthritis and related diseases
- solid organ transplant
|
Its products include:
- PLAVIX for protection against fatal or non-fatal heart attack or stroke
- AVAPRO/AVALIDE for the treatment of hypertension and diabetic nephropathy
- REYATAZ and SUSTIVA Franchise for the treatment of HIV
- BARACLUDE for the treatment of chronic hepatitis B infection
|
|
- ERBITUX, SPRYCEL, and IXEMPRA for treating oncology related diseases
- ABILIFY, a medicine for the treatment of mental illness
- ORENCIA, a medicine for rheumatoid arthritis
- ONGLYZA for the treatment of type 2 diabetes
|
|
|
|
|
Products
Sorry, you need to be a member to see this page.
|
Financial Information
Sorry, you need to be a member to see this page.
|
Market Information:
Sorry, you need to be a member to see this page.
|
Employment
Sorry, you need to be a member to see this page.
|